Lipid peroxidation may predict restenosis after coronary balloon angioplasty

Japanese Circulation Journal

Volumn 65, Issue 6, 2001, Pages 495-499

  Imai, K ^a   Matsubara, T ^a   Kanashiro, M ^a   Ichimiya, S ^a   Hotta, N ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary balloon angioplasty; Lipid peroxidation; Restenosis; Thiobarbituric acid reactive substances

Indexed keywords

LIPID; THIOBARBITURIC ACID;

ADULT; AGED; ANGIOGRAPHY; ARTERY WALL; ARTICLE; BLOOD SAMPLING; CORONARY ARTERY DILATATION; FEMALE; FOLLOW UP; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; RESTENOSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; FEMALE; HUMANS; LIPID PEROXIDATION; LIPIDS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0035009643     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.65.495     Document Type: Article

References (38)

1. Percutaneous transluminal coronary angioplasty
2. Restenosis after successful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 299 patients
3. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease
4. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
5. Long-term prognosis in achieving a 'stent-like' result from balloon angioplasty: 8 Years' clinical outcome
6. Vitamin E consumption and the risk of coronary disease in women
7. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury: A possible role for antioxidants in restenosis
8. Combination of vitamin C and E alters the response to coronary balloon injury in the pig
9. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA)
10. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty
11. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: The Probucol Angioplasty Restenosis Trial
12. Effects of probucol on vascular remodeling after coronary angioplasty
13. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins
14. Methods to determine oxidation of low-density lipoproteins
15. Transient release of lipid peroxidation products as a non-invasive marker of successful reperfusion after thrombolysis for myocardial infarction
16. Lipid peroxides and atherosclerosis
17. Elevated plasma lipid hydroperoxides in patients with coronary artery disease
18. Guidelines for percutaneous transluminal coronary angioplasty: A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on percutaneous transluminal coronary angioplasty)
19. Assay for serum lipid peroxide level and its clinical significance
20. Cypridina luciferin analog reduces the incidence of ischemia/reperfusion-induced ventricular fibrillation
21. A call for provisional stenting: The balloon is back!
22. Molecular biology: Insight into the causes and prevention of restenosis after arterial intervention
23. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression
24. Inhibition by probucol of interleukin I secretion and its implication in atherosclerosis
25. The oxidation hypothesis of atherosclerosis
26. Atherosclerosis: An inflammatory disease
27. Lipoprotein oxidation and progression of carotid atherosclerosis
28. Beyond cholesterol reduction in coronary heart disease: Is vitamin E the answer?
29. Methodological approaches for assessing lipid and protein oxidation and modification in plasma and isolated lipoproteins
30. Evidence for oxidative stress in unstable angina
31. The relationship between serum lipoprotein(a) and restenosis after initial elective percutaneous transluminal coronary angioplasty
32. Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty
33. Autoantibodies to oxidized low density lipoproteins in restenosis following coronary angioplasty
34. Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty
35. Restenosis after successful coronary angioplasty: Pathophysiology and prevention
36. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment
37. Intravascular ultrasound imaging of human coronary arteries in vivo: Analysis of tissue characterizations with comparison to in vitro histological specimens
38. Regional remodeling of atherosclerotic arteries: A major determinant of clinical manifestations of disease